Skip to main content

Public Health Law § 3220 · Article 32-A. Recombinant Dna Experiments

Findings

Verbatim from the official edition

Text — Law content up to date as of October 9, 2026, as published by the New York State Senate (Open Legislation)

§ 3220. Findings. The legislature finds that new techniques of genetic manipulation which allow researchers to accomplish exchanges of genetic material between unlike organisms offer great potential for expanding human knowledge of genetics but also may present significant risks to public health, to the environment and to the health of research workers. These experiments are being conducted at research institutions in New York, including universities, hospitals and industrial facilities. Industry plans to mass-produce recombinant organisms should such organisms be found to have commercial uses. Such research and production should only be conducted under safe conditions as prescribed by the commissioner.

Source of truth

Edition
Law content up to date as of October 9, 2026, as published by the New York State Senate (Open Legislation)
Official file
https://legislation.nysenate.gov/pdf/laws/PBH3220
Text hash
sha256 e2a8ec9aaae6812469fb8d714d6b64c22894a1db099671cc3aaec2704de70571
Composed by
gen_ny_statutes.py 2026-11-10: the Senate's Open Legislation law tree (GET /api/3/laws/<ID>?full=true) read in document order; the Senate's PDF of the whole law (GET /pdf/laws/<ID>?full=true), read with PDFium, prints the same words in the same order

Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.